Oral Wegovy at 5 Months: What the Real-World Data Shows
The Wegovy pill launched January 2026 as the first oral GLP-1 for weight loss. Five months later, here's what we know beyond the clinical trial data.
OASIS 4 trial: 16.6% weight loss (adherent) / 13.6% (all patients) at 64 weeks
Self-pay: $149/month (cheapest brand-name GLP-1)
Dosing: Once daily, empty stomach, 30-min wait before food
No refrigeration required
What Clinical Trials Showed
OASIS 4 enrolled 307 adults. Key results at 64 weeks:1
- 76.3% achieved ≥5% weight loss vs 31.3% placebo
- 34.4% achieved ≥20% weight loss vs 2.9% placebo
- 70%+ of prediabetic participants normalized blood glucose
- Improvements in blood pressure, cholesterol, triglycerides
The $149 Price Point
Novo Nordisk priced oral Wegovy to compete directly with compounded alternatives — and it's working. At $149/month, it undercuts many compounded semaglutide providers while offering FDA-approved status, no needles, and no refrigeration. Insurance co-pays can be as low as $25/month.2
The 30-Minute Rule in Practice
The most discussed practical issue: oral Wegovy must be taken on an empty stomach with ≤4oz water, then 30 minutes before food, drinks, or other medications. Early adopters report building it into morning routines — take the pill, then shower and get ready before breakfast.
Sesame Care · brand-name Rx
Ask About Oral Wegovy →Prescribes FDA-approved brand-name medications. Paid link
Compounded Alternatives Remain Available
$130/mo sema
Check Eligibility → Paid linkCompounded medications are not FDA-approved.
from $129/mo
Check Eligibility → Paid linkCompounded medications are not FDA-approved.
from $179/mo
Check Eligibility → Paid linkCompounded medications are not FDA-approved.
The Source Summary
Oral Wegovy delivers clinical trial-grade weight loss in a $149/month pill with no needles or refrigeration. The 30-minute fasting rule is the main practical trade-off. Five months post-launch, it has reshaped the GLP-1 value proposition for patients weighing brand-name vs compounded options.
Sources
- Wharton S, et al. OASIS 4 trial results. NEJM 2025.
- Novo Nordisk press release, Wegovy pill pricing, December 22, 2025.